These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 15625860)
1. Synthesis of a nonreducible cyclic analog of somatostatin having only growth hormone release inhibiting activity. Garsky VM; Clark DE; Grant NH Biochem Biophys Res Commun; 1976 Dec; 73(4):911-6. PubMed ID: 15625860 [TBL] [Abstract][Full Text] [Related]
2. Somatostatin antagonist analog increases GH, insulin, and glucagon release in the rat. Fries JL; Murphy WA; Sueiras-Diaz J; Coy DH Peptides; 1982; 3(5):811-4. PubMed ID: 6129618 [TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological activity of highly potent octapeptide analogs of somatostatin. Cai RZ; Szoke B; Lu R; Fu D; Redding TW; Schally AV Proc Natl Acad Sci U S A; 1986 Mar; 83(6):1896-900. PubMed ID: 2869490 [TBL] [Abstract][Full Text] [Related]
4. Superactive octapeptide somatostatin analogs containing tryptophan at position 1. Cai RZ; Karashima T; Guoth J; Szoke B; Olsen D; Schally AV Proc Natl Acad Sci U S A; 1987 Apr; 84(8):2502-6. PubMed ID: 2882520 [TBL] [Abstract][Full Text] [Related]
5. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release. Karashima T; Cai RZ; Schally AV Life Sci; 1987 Aug; 41(8):1011-9. PubMed ID: 2886886 [TBL] [Abstract][Full Text] [Related]
7. Synthesis and conformational study of a cyclic hexapeptide analog of somatostatin containing dehydrophenylalanine. Brady SF; Cochran DW; Nutt RF; Holly FW; Bennett CD; Paleveda WJ; Curley PE; Arison BH; Saperstein R; Veber DF Int J Pept Protein Res; 1984 Feb; 23(2):212-22. PubMed ID: 6142022 [TBL] [Abstract][Full Text] [Related]
8. A super active cyclic hexapeptide analog of somatostatin. Veber DF; Saperstein R; Nutt RF; Freidinger RM; Brady SF; Curley P; Perlow DS; Paleveda WJ; Colton CD; Zacchei AG Life Sci; 1984 Apr; 34(14):1371-8. PubMed ID: 6143233 [TBL] [Abstract][Full Text] [Related]
9. Novel sst(4)-selective somatostatin (SRIF) agonists. 1. Lead identification using a betide scan. Rivier J; Erchegyi J; Hoeger C; Miller C; Low W; Wenger S; Waser B; Schaer JC; Reubi JC J Med Chem; 2003 Dec; 46(26):5579-86. PubMed ID: 14667212 [TBL] [Abstract][Full Text] [Related]
10. Studies on growth hormone secretion. VII. Effects of somatostatin on plasma GH, insulin, and glucagon in sheep. Bryce D; Yeh M; Funderburk C; Todd H; Hertelendy F Diabetes; 1975 Sep; 24(9):842-50. PubMed ID: 169176 [TBL] [Abstract][Full Text] [Related]
13. Inhibition of rat prostate tumor growth by an octapeptide analog of somatostatin. Murphy WA; Lance VA; Moreau S; Moreau JP; Coy DH Life Sci; 1987 Jun; 40(26):2515-22. PubMed ID: 2885701 [TBL] [Abstract][Full Text] [Related]
14. Synthesis and biological activity of a cyclic pseudohexapeptide analog of somatostatin. Gero TW; Spatola AF; Torres-Aleman I; Schally AV Biochem Biophys Res Commun; 1984 May; 120(3):840-5. PubMed ID: 6145411 [TBL] [Abstract][Full Text] [Related]
15. Relative effects of somatostatin and two somatostatin analogues on the release of insulin, glucagon and growth hormone. Efendić S; Luft R; Sievertsson H FEBS Lett; 1975 Oct; 58(1):302-5. PubMed ID: 1225595 [No Abstract] [Full Text] [Related]
16. Comparative effects of somatostatin-28 and somatostatin-14 on basal growth hormone release and pancreatic function in immature ducks (Anas platyrhynchos). Strosser MT; Harvey S; Foltzer C; Mialhe P Gen Comp Endocrinol; 1984 Nov; 56(2):265-70. PubMed ID: 6150878 [TBL] [Abstract][Full Text] [Related]
17. Dissociation of somatostatin effects. Peptides inhibiting the release of growth hormone but not glucagon or insulin in rats. Grant N; Clark D; Garsky V; Jaunakais I; McGregor W; Sarantakis D Life Sci; 1976 Sep; 19(5):629-31. PubMed ID: 957897 [No Abstract] [Full Text] [Related]
18. Observations on the growth hormone, insulin, and glucagon release-inhibiting activities of somatostatin analogues. Coy DH; Meyers C; Arimura A; Schally AV; Redding TW Metabolism; 1978 Sep; 27(9 Suppl 1):1407-10. PubMed ID: 683009 [No Abstract] [Full Text] [Related]
19. Selective inhibitory effect of the analog D5-F-TrP8-D-Cys14 somatostatin on the arginine induced release of insulin, growth hormone and glucagon, in normal human beings. González-Bárcena D; Mendoza F; Graef A; Medina R; Comaru-Schally AM; Schally AV Arch Invest Med (Mex); 1985; 16 Suppl 3():105-14. PubMed ID: 2878649 [No Abstract] [Full Text] [Related]
20. Synthesis and biological activity of highly potent heptapeptide analogs of somatostatin with C-terminal modifications. Janecka A; Zubrzycka M Endocr Regul; 2001 Jun; 35(2):75-9. PubMed ID: 11563935 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]